GRDX Company Profile and Key Details

GRDX has shown weak momentum, losing -19.01% over the past week and -33.87% over the past quarter, though year-to-date performance is down -29.61%. Short-term trend indicators are mixed aligned (SMA20 -15.04%, SMA50 -25.68%, SMA200 -12.42%). The stock’s 14-day RSI is 40.18 (neutral), while the ATR of 0.42 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -58.56% below its high and over 149.66% above its low. Average 10-day trading volume of 204.61 thousand shares is significantly above the 3-month average of 116.92 thousand, indicating heightened recent market interest.

GridAI Technologies Corp. generated EPS of -$10.06 over the past year. Five-year average earnings growth is 82.03%. GridAI Technologies Corp. earnings surprise history is a mixed track record. The quarter that ended February 25, 2026, missed forecasts by -99.97%. The prior quarter beat by 536.59%. Over the last six quarters, Apple has recorded several small beats. These include 536.59% in April 04, 2025.

GridAI Technologies Corp. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.73. This means the shares are trading below this model’s fair value.

GridAI Technologies Corp. (NASDAQ:GRDX) closed at $4.84 USD, gaining $0.23 (4.99%) from the previous close of $4.61. The stock is currently mid-range between its 52-week high and low $1.06 and $5.84. With a market capitalization of about $16.27 million, GridAI Technologies Corp. is classified as a micro-cap and shows higher-than-market volatility (beta ~1.39). Key stats such as the average daily volume over the past year has been around 115.72 thousand shares, trading with heavier-than-usual volume. Headquartered in Boca Raton, FL, GridAI Technologies Corp. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Jason David Sawyer, the company employs approximately 2 people and listed since October 11, 2016. GridAI Technologies Corp. is a clinical stage biopharmaceutical company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases.

Our AI price prediction model suggests that GridAI Technologies Corp. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 21.28%, with price expected at $5.87 by June 05, 2026, within a range of $5.62 to $6.13 3-Month Outlook: Projected fall of -100.0%, reaching $0.00 by August 20, 2026, with a range of $0.00 to $0.00. 1-Year Outlook: Projected gain of 475.0%, with price at $27.83 by May 21, 2027, within a range of $27.77 to $27.89.

GridAI Technologies Corp. (NASDAQ:GRDX) shares are down -29.61% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows GridAI Technologies Corp. trading at a premium to the broader market with a P/E of -1.19. Our AI forecast model points to short-term strength (21.28% over two weeks), a medium-term fall (-100.0% over three months), and a longer-term gain (475.0% over one year), with expected trading ranges indicating moderate volatility.

GridAI Technologies Corp. trades at a P/E ratio of -1.19, slightly below the S&P 500 average, with a price-to-sales ratio of 448.86 and a price-to-book ratio of 0.33 suggesting the stock is closer to book value. The P/FCF stands at -2.85, also above market averages.